Global Health Ltd. (MEDANTA) Share Price Falls 3.43% Amid Market Volatility
- July 31, 2026
- Posted by: Harsh Piplani
- Category: News
Global Health Ltd. Share Price fell 3.43% to Rs 1,367 today, with a market cap of Rs 38,518.57 crore.
Global Health Ltd. Share Price experienced a significant decline today, falling by 3.43% to close at Rs 1,367. This decline positions the company within the Large Cap category, with a market capitalisation of Rs 38,518.57 crore.
The decline in Global Health Ltd.’s share price today reflects broader market volatility, although the specific catalyst for this movement is not identified in the available data. Investors and analysts will be closely monitoring the stock’s performance in the coming days to assess any potential recovery or further declines.
Global Health Ltd. (MEDANTA) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,367 |
| Previous Close | Rs 1,415.6 |
| Today's Change | Rs -48.6 (-3.43%) |
| Day Open | Rs 1,399.95 |
| Day High | Rs 1,399.95 |
| Day Low | Rs 1,337.2 |
| Current Volume (BSE) | 6,858 |
| BSE Traded Volume | 6,858 |
| NSE Traded Volume | 1,09,329 |
| Combined NSE + BSE Volume | 1,16,187 |
| Turnover | Rs 0.94 crore |
| Market Capitalisation | Rs 38,518.57 crore |
| Market Cap Category | Large Cap |
Global Health Ltd. (MEDANTA) traded at Rs 1,367. versus the previous close of Rs 1,415.6, a fall of 3.43%. The stock opened at Rs 1,399.95, reached Rs 1,399.95, touched Rs 1,337.2. Reported volume was 6,858.
Global Health Ltd. (MEDANTA) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 38,518.57 crore |
The Healthcare sector’s benchmark data reveals a median P/E of 25.77 and a median P/B of 1.93, providing a context for evaluating Global Health Ltd.’s valuation. The sector’s average ROE and ROCE are 15.09% and 17.57%, respectively, which serve as benchmarks for assessing the company’s profitability and capital efficiency.
While detailed financial metrics for Global Health Ltd. are not available, the sector data suggests that the company operates in a competitive environment with varying levels of profitability and valuation among peers. Investors should consider these factors when evaluating the company’s potential for growth and value creation.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Benchmark Scope | same sector |
| Benchmark Median P/E | 25.77x |
| Benchmark Average P/E | 94.79x |
| Benchmark P/E Range | 3.3x to 3,417.8x |
| Benchmark Median P/B | 1.93x |
| Benchmark Median ROE | 10.74% |
| Benchmark Median ROCE | 13.24% |
| Company Market Capitalisation | Rs 38,518.57 crore |
| Benchmark Median Market Cap | Rs 140.91 crore |
Global Health Ltd. (MEDANTA) is classified under sector: Healthcare.
Track today’s top decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.
Global Health Ltd. is part of the Healthcare sector, which includes a wide range of companies involved in pharmaceuticals, biotechnology, and healthcare services. The sector comprises 198 companies, with a median market capitalisation of Rs 140.91 crore, highlighting the diversity in company sizes within the sector.
The sector’s P/E ratio ranges from a minimum of 3.3 to a maximum of 3417.8, with a median of 25.77. This wide range indicates significant variability in valuation across the sector, influenced by factors such as growth prospects, profitability, and market sentiment. The P/B ratio also shows variability, with a median of 1.93, reflecting differences in asset valuation and financial leverage among companies.
Global Health Ltd.’s position within this sector suggests that it operates in a dynamic and competitive environment, where market conditions and industry trends can significantly impact performance. Investors should consider these sector dynamics when assessing the company’s potential for long-term growth and stability.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Dishman Carbogen Amcis Ltd. | DCAL | 2,950.66 | 0 | 0.75 | -2.89 | -0.26 |
| Hikal Ltd. | HIKAL | 2,726.18 | 0 | 2.23 | 15.22 | 16.15 |
| Kwality Pharmaceuticals Ltd. | KPL | 2,700.98 | 39.17 | 7.93 | 28.21 | 26.35 |
| Panacea Biotec Ltd. | PANACEABIO | 2,598.26 | 0 | 8.89 | 0 | 5.36 |
| Beta Drugs Ltd. | BETA | 2,475.7 | 58.88 | 9.32 | 18.65 | 22.17 |
Global Health Ltd. (MEDANTA) has a market capitalisation of Rs 38,518.57 crore. Among the 5 peers shown, 0 have a larger market capitalisation.
In comparison to its peers, Global Health Ltd. stands out due to its larger market capitalisation of Rs 38,518.57 crore. Peers such as Dishman Carbogen Amcis Ltd. and Hikal Ltd. have market caps of Rs 2,950.66 crore and Rs 2,726.18 crore, respectively, indicating a smaller scale of operations.
These comparisons underscore the importance of evaluating Global Health Ltd.’s financial performance and market position relative to its peers to make informed investment decisions.
Why Investors Are Watching Global Health Ltd.
Investors are closely monitoring Global Health Ltd. due to its significant price movement and position within the Healthcare sector. Key factors include:
- Today’s 3.43% price fall, surpassing the Large Cap threshold.
- Market capitalisation of Rs 38,518.57 crore, indicating a substantial market presence.
- Sector dynamics and peer comparisons highlighting competitive positioning.
As market conditions evolve, investors should continue to track Global Health Ltd.’s performance and sector developments to assess potential investment opportunities.
About Global Health Ltd.
Global Health Ltd. operates within the Healthcare sector, providing a range of services and products that contribute to its market position. The company is involved in various segments of the healthcare industry, including pharmaceuticals and healthcare services, which are critical to its revenue generation and growth strategy.
As a significant player in the sector, Global Health Ltd. benefits from its scale and market presence, enabling it to compete effectively with other companies in the industry. The company’s focus on innovation and quality service delivery positions it well for future growth and expansion within the dynamic healthcare landscape.
Track Global Health Ltd. Share Price on Univest
Use Global Health Ltd. (MEDANTA) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners lists and related market analysis.
Investors can track Global Health Ltd. Share Price and other key metrics on Univest. The platform provides live updates on share price, technical indicators, fundamental ratios, shareholding patterns, and market insights, offering valuable information for informed investment decisions.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What caused the decline in Global Health Ltd. Share Price today?
Ans. The specific catalyst for Global Health Ltd.'s 3.43% share price decline today is not identified in the available data, reflecting broader market volatility. The stock moved -3.43% during the session.
How does Global Health Ltd.'s market cap compare to its peers?
Ans. Global Health Ltd.'s market cap of Rs 38,518.57 crore is significantly larger than peers like Dishman Carbogen Amcis Ltd. (Rs 2,950.66 crore) and Hikal Ltd. (Rs 2,726.18 crore). The company operates in the Healthcare sector.
What is the sector benchmark P/E for Healthcare?
Ans. The sector benchmark P/E for Healthcare is a median of 25.77, with a wide range from 3.3 to 3417.8, indicating significant variability in valuations. The relevant peer median P/E is 25.77x.
How does the Healthcare sector's P/B ratio compare?
Ans. The Healthcare sector's median P/B ratio is 1.93, with a range from -16.68 to 16.05, reflecting diverse asset valuations. The relevant peer median P/E is 25.77x. The peer average P/E is 94.79x.
What is the sector benchmark ROE for Healthcare?
Ans. The sector benchmark ROE for Healthcare is a median of 10.74%, indicating the average return on equity within the sector. The relevant peer median ROE is 10.74%. The relevant peer median ROCE is 13.24%.
How does Global Health Ltd.'s ROCE compare to the sector?
Ans. The sector benchmark ROCE is 13.24%, providing a context for assessing Global Health Ltd.'s capital efficiency and profitability. The relevant peer median ROE is 10.74%. The relevant peer median ROCE is 13.24%.
